Improvements in Treatment-Resistant Depression With Esketamine
(MedPage Today) -- Esketamine nasal spray (Spravato) combined with an oral antidepressant for treatment-resistant depression reduced depression severity and led to numerically more remissions during maintenance, post-hoc analyses of three phase...
Read more »